Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911935 · ClinicalTrials.gov registry record · Phase 2
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II
A Phase 2 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT02911935 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 200 participants.
The verdict
NCT02911935, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The main objective of the APW-RSV II clinical trial is to evaluate if the addition of azithromycin to routine bronchiolitis care, among infants hospitalized with RSV bronchiolitis, reduces the occurrence of recurrent wheeze during the preschool years.
Interventions
- DRUG Placebo
- DRUG Oral azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2016-11 |
| Est. Completion | 2021-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02911935
The ClinicalTrials.gov registry entry for NCT02911935 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02911935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02911935 about?
NCT02911935 is a clinical study titled "Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II". The main objective of the APW-RSV II clinical trial is to evaluate if the addition of azithromycin to routine bronchiolitis care, among infants hospitalized with RSV bronchiolitis, reduces the occurrence of recurrent wheeze during the preschool years.
What is the current status of trial NCT02911935?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2016-11. Estimated completion is 2021-04.
What interventions are being tested in trial NCT02911935?
The interventions under investigation include: Placebo (DRUG), Oral azithromycin (DRUG).
Who is sponsoring clinical trial NCT02911935?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.